title: Inhibition of chemokine (C-X-C motif) receptor four (CXCR4) at the fetal-maternal interface during early gestation in sheep: alterations in expression of chemokines, angiogenic factors and their receptors.
abstract: Chemokine (C-X-C motif) ligand 12 (CXCL12) and its receptor, chemokine (C-X-C motif) receptor 4 (CXCR4), are involved in significant biological processes associated with early pregnancy including increasing trophoblast invasion and stimulating placental vascularization. To further elucidate functions of CXCL12-CXCR4 signaling during early gestation, our objective was to inhibit CXCR4 in vivo using a CXCR4 antagonist, AMD3100. We hypothesized that inhibition of CXCR4 would negatively affect chemokine and angiogenic factor regulation imperative for placental development in sheep. Osmotic pumps containing PBS (control) or AMD3100 (CXCR4 antagonist) were surgically installed ipsilateral to the corpus luteum on d 12 of gestation and administered treatments directly into the uterine lumen. Maternal (caruncle and intercaruncle) and fetal membrane tissues were collected on d 23 of gestation and mRNA and protein expression were analyzed for vascular endothelial growth factor (VEGF), kinase insert domain receptor (KDR), fms related tyrosine kinase 1 (FLT1), fibroblast growth factor 2 (FGF2), angiopoietin 1 (ANGPT1), hypoxia inducible factor 1 ɑ subunit (HIF1A), CXCL12, and its corresponding receptors (CXCR4 and CXCR7). Immunohistochemical procedures were performed for analysis of CXCL12 and cell proliferation. In caruncle tissue ipsilateral to the pump, mRNA forKDR,ANGPT1,HIF1A, andCXCL12increased (P< 0.05) in treated ewes compared to control, whereas caruncle tissue contralateral to the pump had increased expression (P< 0.05) ofKDR, andCXCL12in treated ewes. In fetal membrane,CXCR4mRNA and protein decreased (P< 0.05), while VEGF protein decreased (P< 0.05) in caruncle and fetal membrane tissue from treated ewes. Results from this study highlight the importance of CXCL12-CXCR4 signaling at the fetal-maternal interface. Inhibiting this axis may disrupt typical regulation of angiogenic factors needed for placental development and embryo growth.
authors.forename: K E
authors.initials: KE
authors.lastname: Quinn
authors.forename: S Z
authors.initials: SZ
authors.lastname: Prosser
authors.forename: K K
authors.initials: KK
authors.lastname: Kane
authors.forename: R L
authors.initials: RL
authors.lastname: Ashley
mesh_terms: D043924:Angiogenesis Modulating Agents / Q000378:metabolism*; D000818:Animals; D049109:Cell Proliferation; D054377:Chemokine CXCL12 / Q000235:genetics / Q000378:metabolism*; D018925:Chemokines / Q000235:genetics / Q000378:metabolism*; D003338:Corpus Luteum; D005260:Female; D008431:Maternal-Fetal Exchange / Q000502:physiology*; D010920:Placenta / Q000098:blood supply; D010929:Placentation / Q000502:physiology; D011247:Pregnancy; D012333:RNA, Messenger / Q000378:metabolism; D054387:Receptors, CXCR / Q000235:genetics / Q000378:metabolism*; D012756:Sheep / Q000502:physiology*; D015398:Signal Transduction; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
chemical_list: D043924:Angiogenesis Modulating Agents; D054377:Chemokine CXCL12; D018925:Chemokines; D012333:RNA, Messenger; D054387:Receptors, CXCR; D042461:Vascular Endothelial Growth Factor A